NZ189625A - Amino sugar derivatives(trestatin a b and c) and amylase inhibiting compositions - Google Patents

Amino sugar derivatives(trestatin a b and c) and amylase inhibiting compositions

Info

Publication number
NZ189625A
NZ189625A NZ189625A NZ18962579A NZ189625A NZ 189625 A NZ189625 A NZ 189625A NZ 189625 A NZ189625 A NZ 189625A NZ 18962579 A NZ18962579 A NZ 18962579A NZ 189625 A NZ189625 A NZ 189625A
Authority
NZ
New Zealand
Prior art keywords
trestatin
sugar derivatives
amino sugar
inhibiting compositions
amylase inhibiting
Prior art date
Application number
NZ189625A
Other languages
English (en)
Inventor
K Watanabe
K Ogawa
Y Suhara
K Yokose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ189625A publication Critical patent/NZ189625A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ189625A 1978-02-14 1979-02-12 Amino sugar derivatives(trestatin a b and c) and amylase inhibiting compositions NZ189625A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14

Publications (1)

Publication Number Publication Date
NZ189625A true NZ189625A (en) 1981-05-01

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ189625A NZ189625A (en) 1978-02-14 1979-02-12 Amino sugar derivatives(trestatin a b and c) and amylase inhibiting compositions

Country Status (26)

Country Link
US (1) US4273765A (enExample)
EP (1) EP0003616B1 (enExample)
JP (1) JPS54163511A (enExample)
AR (1) AR219150A1 (enExample)
AT (1) AT367451B (enExample)
AU (1) AU527318B2 (enExample)
CA (1) CA1121290A (enExample)
DE (2) DE2962165D1 (enExample)
DK (1) DK149599C (enExample)
ES (1) ES477653A1 (enExample)
FI (1) FI63062C (enExample)
FR (1) FR2416901A1 (enExample)
GR (1) GR72817B (enExample)
HU (1) HU181442B (enExample)
IE (1) IE47916B1 (enExample)
IL (1) IL56626A0 (enExample)
LU (1) LU80906A1 (enExample)
MC (1) MC1253A1 (enExample)
NL (1) NL7901182A (enExample)
NO (1) NO153011C (enExample)
NZ (1) NZ189625A (enExample)
PH (1) PH15084A (enExample)
PT (1) PT69218A (enExample)
SE (1) SE7901276L (enExample)
YU (1) YU41437B (enExample)
ZA (1) ZA79528B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056194B1 (en) 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
DE69115926T2 (de) * 1990-11-30 1996-05-30 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
DK1157696T3 (da) * 2000-05-24 2007-02-12 Pfizer Behandling af rumen-acidose med alpha-amylaseinhibitorer
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
RU2422450C2 (ru) 2003-11-19 2011-06-27 Метабазис Терапеутикс, Инк. Новые фосфорсодержащие тиромиметики
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
BRPI0518300A2 (pt) * 2004-11-23 2008-11-11 Warner Lambert Co derivados de Ácido 7-(2h-pirazol-3-il)-3,5-diidràxi-heptanàico como inibidores da hmg co-a reductase para o tratamento de lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CN101998998A (zh) 2008-04-11 2011-03-30 安斯泰来制药株式会社 氨基糖化合物及其生产方法
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828343A1 (en) 2011-03-04 2012-09-13 The Scripps Research Institute Edn3-like peptides and uses thereof
MY188344A (en) 2012-03-09 2021-12-01 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
RU2746405C2 (ru) 2014-08-29 2021-04-13 Тес Фарма С.Р.Л. ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ-ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JP2020500838A (ja) 2016-10-14 2020-01-16 ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ Α−アミノ−β−カルボキシムコン酸セミアルデヒドデカルボキシラーゼの阻害剤
IL283182B2 (en) 2018-11-20 2025-10-01 Tes Pharma S R L Alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase inhibitors
PL3911648T3 (pl) 2019-01-18 2025-03-10 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksy)-2- pirymidynylo]amino]cyklopentylo]amino][1(2h),3'-bipirydyn]-2-on jako inhibitor pcsk9 i sposoby jego zastosowania

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
AR219150A1 (es) 1980-07-31
EP0003616B1 (de) 1982-02-24
US4273765A (en) 1981-06-16
IL56626A0 (en) 1979-05-31
SE7901276L (sv) 1979-08-15
GR72817B (enExample) 1983-12-06
DK61179A (da) 1979-08-15
CA1121290A (en) 1982-04-06
FI790486A7 (fi) 1979-08-15
IE790274L (en) 1979-08-14
PH15084A (en) 1982-07-02
NL7901182A (nl) 1979-08-16
DE2905649A1 (de) 1979-08-16
ATA108879A (de) 1981-11-15
PT69218A (en) 1979-03-01
AU4402879A (en) 1979-08-23
YU34879A (en) 1983-01-21
NO153011C (no) 1986-01-02
FI63062B (fi) 1982-12-31
MC1253A1 (fr) 1980-01-14
YU41437B (en) 1987-06-30
HU181442B (en) 1983-07-28
EP0003616A2 (de) 1979-08-22
LU80906A1 (de) 1980-09-24
DK149599C (da) 1987-06-01
JPS643877B2 (enExample) 1989-01-23
IE47916B1 (en) 1984-07-25
AT367451B (de) 1982-07-12
NO790469L (no) 1979-08-15
NO153011B (no) 1985-09-23
FR2416901A1 (fr) 1979-09-07
ES477653A1 (es) 1980-03-01
EP0003616A3 (en) 1979-09-05
JPS54163511A (en) 1979-12-26
FI63062C (fi) 1983-04-11
AU527318B2 (en) 1983-02-24
FR2416901B1 (enExample) 1980-10-24
DE2962165D1 (en) 1982-03-25
ZA79528B (en) 1980-02-27
DK149599B (da) 1986-08-04

Similar Documents

Publication Publication Date Title
NZ189625A (en) Amino sugar derivatives(trestatin a b and c) and amylase inhibiting compositions
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
IL57450A (en) Aminothiazole derivatives and pharmaceutical compositions containing them
DE2964135D1 (en) Pharmaceutical compositions containing urea
JPS543085A (en) Somatostatin homologues*compositions and preparations
AU514686B2 (en) Herbicidal compositions and herbicidal processes
NZ188170A (en) Propenylamines and pharmaceutical compositions
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
NZ189705A (en) Benzophenone-hydrazone derivatives and pesticidal compositions intermediates
IL58730A (en) Spiro-polycyclic imidazolidinedione derivatives and pharmaceutical compositions containing them
NZ192234A (en) Pyrimidine derivatives and herbicidal compositions
NZ192548A (en) (1-heterocyclyl-alkoxy) alkyl-oxolanes and herbicidal compositions
NZ186096A (en) Phenylcarbamoyl-2-pyrazdine derivatives and pesticidal compositions
NZ188500A (en) Trifluoromethylphenoxy-phenoxy-crotonic acid derivatives and herbicidal compositions
IL53783A0 (en) Imidazotriazine derivatives and herbicidal compositions containing them
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
ZA803538B (en) Sugar derivatives
NZ189593A (en) Thiazolidinone derivatives and pesticidal compositions
NZ187478A (en) N-acylmethylchloroacetanilide derivatives and herbicidal compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ191229A (en) Phenyliminomethyl-pyridine derivatives and pesticidal compositions intermediates
IL58621A0 (en) Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
NZ189769A (en) Benzylidene derivatives and pharmaceutical compositions
JPS53124181A (en) Aerosol adhering composition